Larvol Delta - AltruBio-Hosting-Research-amp-Development-Update-on-Immune-Checkpoint-Enhancer-Platform-for-T-Cell-Mediated-Immunological-Diseases

neihulizumab (ALTB-168) - AltruBio

leiolizumab (ALTB-268) - AltruBio

https://www.globenewswire.com/news-release/2022/12/08/2570181/0/en/AltruBio-Hosting-Research-Development-Update-on-Immune-Checkpoint-Enhancer-Platform-for-T-Cell-Mediated-Immunological-Diseases.html

Dec 8, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next